Type 2 Diabetes Mellitus and Tuberculosis, the next syndemic

Authors

  • Roberto Zenteno-Cuevas Universidad Veracruzana, México; Red Multidisciplinaria de Investigación en Tuberculosis, México https://orcid.org/0000-0001-9597-127X
  • Axhell Aleid Cornejo-Báez Universidad Veracruzana, México; Instituto Politécnico Nacional, Ciudad de México, México
  • Damián E. Pérez-Martínez Universidad Veracruzana, México https://orcid.org/0000-0002-8217-0761

DOI:

https://doi.org/10.54034/mic.e1821

Keywords:

tuberculosis, diabetes mellitus, syndemic

References

Global tuberculosis report 2020 [Internet]. [cited 2021 Nov 2]. Available from: https://www.who.int/publications/i/item/9789240013131

World Health Organisation. tuberculosis Global Report 2018. World Health Organization Geneva. 2018.

Badawi A, Sayegh S, Sallam M, Sadoun E, Al-Thani M, Alam MW asi., et al. The global relationship between the prevalence of diabetes mellitus and incidence of tuberculosis: 2000-2012. Glob J Health Sci. 2015;

International Diabetes Federation. IDF DIABETES ATLAS 8th. IDF Diabetes Atlas, 8th edition. 2017.

Jeon CY, Murray MB. Diabetes Mellitus Increases the Risk of Active Tuberculosis : A Systematic Review of 13 Observational Studies. PLoS Med. 2008;5(7):1091–101.

Yew WW, Leung CC, Zhang Y. Oxidative stress and TB outcomes in patients with diabetes mellitus? J Antimicrob Chemother. 2017;

Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Med. 2011;9(1):81.

Chang JT, Dou HY, Yen CL, Wu YH, Huang RM, Lin HJ, et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: A potential role in the emergence of multidrug-resistance. J Formos Med Assoc. 2011;

Pérez-Navarro LM, Fuentes-Domínguez FJ, Zenteno-Cuevas R. Type 2 diabetes mellitus and its influence in the development of multidrug resistance tuberculosis in patients from southeastern Mexico. J Diabetes Complications [Internet]. 2015;29(1):77–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25303784

Babalik A, Ulus IH, Bakirci N, Kuyucu T, Arpag H, Dagyildizi L, et al. Plasma Concentrations of Isoniazid and Rifampin Are Decreased in Adult Pulmonary Tuberculosis Patients with Diabetes Mellitus. Antimicrob Agents Chemother. 2013 Nov;57(11):5740–2.

WHO. WHO | Global tuberculosis report 2019 [Internet]. World Health Organization, editor. World Health Organization. Geneva: World Health Organization; 2020. Available from: http://apps.who.int/bookorders.%0Ahttps://www.who.int/tb/publications/global_report/en/%0Ahttp://apps.who.int/bookorders.

World Health Organization (WHO). COLLABORATIVE FRAMEWORK FOR CARE AND CONTROL OF TUBERCULOSIS AND DIABETES. 2011.

World Health Organization (WHO). World health statistics 2020. Monitoring healt for the Sustainable Development Goals. 2020.

Downloads

Published

2023-03-10

Issue

Section

EDITORIAL

How to Cite

1.
Type 2 Diabetes Mellitus and Tuberculosis, the next syndemic. Microbes Infect. Chemother. [Internet]. 2023 Mar. 10 [cited 2025 Mar. 21];3:e1821. Available from: https://revistas.unheval.edu.pe/index.php/mic/article/view/1821

Similar Articles

1-10 of 29

You may also start an advanced similarity search for this article.